Incyte Corp at Evercore ISI HealthCONx Conference (Virtual) Transcript
All right. Welcome, everyone. This is Gavin Clark-Gartner from the Evercore ISI Biotech research team, and I'm very happy to be here with the team from Incyte. We have Herve Hoppenot, the Chairman and CEO; Christiana Stamoulis, CFO; and Jim Lee, who is the Head of Information and Autoimmunity Development. Thanks so much for joining us.
Thank you for having us.
Questions & Answers
Yes, absolutely. So we have 20 minutes for our fireside. So we're going to jump right into some more specific question and answers. And maybe the point to start is actually with the Inflation Reduction Act. And first, I just wanted to confirm you have met the small biotech exemption criteria, correct, for -- [at least for Jakafi]. So negotiated price couldn't go
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
